Journal of Surgery Concepts & Practice ›› 2024, Vol. 29 ›› Issue (01): 40-45.doi: 10.16139/j.1007-9610.2024.01.07
• Original article • Previous Articles Next Articles
MO Jiantao, CAO Ruiqi, REN Jiaqiang, GENG Zhimin, WU Zheng, CHENG Yali()
Received:
2024-01-11
Online:
2024-01-25
Published:
2024-05-14
Contact:
CHENG Yali
E-mail:cyl_xa@163.com
CLC Number:
MO Jiantao, CAO Ruiqi, REN Jiaqiang, GENG Zhimin, WU Zheng, CHENG Yali. Construction of a prognostic Nomogram for patients with incidental gallbladder cancer[J]. Journal of Surgery Concepts & Practice, 2024, 29(01): 40-45.
Tab 1
Univariate and multivariate Cox regression analysis of IGBC patients
Variable | Univariate Cox regression analysis | Multivariate Cox regression analysis | |||
---|---|---|---|---|---|
HR(95% CI) | P value | HR(95% CI) | P value | ||
Gender(female vs. male) | 1.40 (0.69-2.80) | 0.360 | |||
Age(>60 vs. ≤60)(year) | 1.90 (1.00-3.30) | 0.038 | |||
Pathological type(other vs. adenocarcinoma) | 1.20 (0.28-4.80) | 0.830 | |||
T(T3+T4 vs. T1+T2) | 3.70 (1.40-9.70) | 0.007 | 3.10(1.05-9.16) | 0.041 | |
N(N1+N2 vs. N0) | 6.3 0(3.00-13.00) | 0.000 | 3.62(1.29-10.22) | 0.015 | |
M(M1 vs. M0) | 13.00 (5.00-34.00) | 0.000 | |||
Preoperative AFP(>25 vs. ≤25)(μg/L) | 1.80 (0.24-13.00) | 0.57 | |||
Preoperative CEA(>5 vs. ≤5)(μg/L) | 5.10 (2.10-13.00) | 0.000 | |||
Preoperative CA12-5(>35 vs. ≤35)(μg/L) | 1.80 (0.93-3.50) | 0.079 | |||
Preoperative CA19-9(>37 vs. ≤37)(μg/L) | 6.30 (3.10-12.00) | 0.000 | 15.42(4.75-50.00) | 0.000 | |
Preoperative RDW-CV(>14.5 vs. ≤14.5) | 3.00(1.10-8.70) | 0.038 | 3.15(1.04-9.55) | 0.043 | |
Preoperative RDW-SD(>56 vs. ≤56)(fl) | 0.00(0-Inf) | 1.000 | |||
Preoperative ALT(>40 vs. ≤40)(U/L) | 1.40 (0.78-2.60) | 0.250 | |||
Preoperative AST(>40 vs. ≤40)(U/L) | 1.80 (0.94-3.50) | 0.077 | 0.27(0.08-0.85) | 0.025 | |
Preoperative total bilirubin (>17.1 vs. ≤17.1) (μmol/L) | 1.60 (0.80-3.10) | 0.190 | |||
Preoperative direct bilirubin (>6.8 vs. ≤6.8) (μmol/L) | 1.90 (0.99-3.70) | 0.055 | |||
Preoperative total protein (>60 vs. ≤60)(g/L) | 0.94 (0.46-1.90) | 0.850 | |||
Therapy (palliative operation vs. radical operation) | 8.30 (4.50-15.00) | 0.000 | 3.35(1.26-8.89) | 0.015 | |
Postoperative drainage(Yes vs. No) | 1.00(0.47-2.30) | 0.910 | |||
Recurrence and metastasis(Yes vs. No) | 5.50 (3.10-9.80) | 0.000 | 4.51(2.08-9.79) | 0.000 | |
Intraoperative bleeding volume (≤500 vs.>500)(mL) | 0.00(0-Inf) | 1.000 | |||
Common bile duct diameter (≤1 vs. >1)(cm) | 0.84 (0.23-3.00) | 0.790 | |||
Hepatectomy method (other vs. S4b+S5) | 0.92 (0.43-2.00) | 0.820 |
[1] | 孙旭恒, 任泰, 耿亚军, 等. 中国胆囊癌外科治疗现状与病理学特征多中心回顾性研究(附4345例报告)[J]. 中国实用外科杂志, 2021, 41(1):99-106. |
SUN X H, REN T, GENG Y J, et al. A large scale multicenter retrospective study of current surgical treatment modalities and pathological characteristics of patients with gallbladder cancer in China:a report of 4,345 cases[J]. Chin J Pract Surg, 2021, 41(1):99-106. | |
[2] |
ROA J C, GARCIA P, KAPOOR V K, et al. Gallbladder cancer[J]. Nat Rev Dis Primers, 2022, 8(1):69.
doi: 10.1038/s41572-022-00398-y pmid: 36302789 |
[3] | 周迪, 全志伟. “意外胆囊癌”更名与重视胆囊良性疾病的规范化诊治[J]. 肝胆胰外科杂志, 2020, 32(11):641-645. |
ZHOU D, QUAN Z W. Renaming "incidental gallbladder cancer" and revisiting the standardised management of benign gallbladder disease[J]. J Hepatopancreatobiliary Surg, 2020, 32(11):641-645. | |
[4] | CAVALLARO A, PICCOLO G, DI VITA M, et al. Mana-ging the incidentally detected gallbladder cancer: algorithms and controversies[J]. Int J Surg, 2014, 12(Suppl 2):S108-S119. |
[5] | DE SAVORNIN LOHMAN E A J, DE BITTER T J J, HANNINK G, et al. Development and external validation of a model to predict overall survival in patients with resected gallbladder cancer[J]. Ann Surg, 2023, 277(4):e856-e863. |
[6] |
WU Y, LI Q, CAI Z, et al. Survival prediction for gallbladder carcinoma after curative resection: comparison of nomogram and Bayesian network models[J]. Eur J Surg Oncol, 2020, 46(11):2106-2113.
doi: 10.1016/j.ejso.2020.07.009 pmid: 32807616 |
[7] | BENSON A B, D'ANGELICA M I, ABBOTT D E, et al. Hepatobiliary Cancers, Version 2.2021, NCCN Clinical Practice Guidelines in Oncology[J]. J Natl Compr Canc Netw, 2021, 19(5):541-565. |
[8] | XIE Z H, SHI X, LIU M Q, et al. Development and validation of a nomogram to predict overall survival in patients with incidental gallbladder cancer: a retrospective cohort study[J]. Front Oncol, 2023,12:1007374. |
[9] |
LUNDGREN L, MUSZYNSKA C, ROS A, et al. Management of incidental gallbladder cancer in a national cohort[J]. Br J Surg, 2019, 106(9):1216-1227.
doi: 10.1002/bjs.11205 pmid: 31259388 |
[10] |
ADDEO P, CENTONZE L, LOCICERO A, et al. Incidental gallbladder carcinoma discovered after laparoscopic cholecystectomy: identifying patients who will benefit from reoperation[J]. J Gastrointest Surg, 2018, 22(4):606-614.
doi: 10.1007/s11605-017-3655-z pmid: 29274001 |
[11] |
SACHAN A, SALUJA S S, NEKARAKANTI P K, et al. Raised CA19-9 and CEA have prognostic relevance in gallbladder carcinoma[J]. BMC Cancer, 2020, 20(1):826.
doi: 10.1186/s12885-020-07334-x pmid: 32867709 |
[12] | CHEN Z, LIU Z, ZHANG Y, et al. Combination of CA19-9 and the neutrophil-to-lymphocyte ratio for the differential diagnosis of gallbladder carcinoma[J]. Cancer Manag Res, 2020,12:4475-4482. |
[13] | BAI Y, LIU Z S, XIONG J P, et al. Nomogram to predict overall survival after gallbladder cancer resection in China[J]. World J Gastroenterol, 2018, 24(45):5167-5178. |
[14] |
WU J, YANG Y, CHENG L, et al. GCdiscrimination: identification of gastric cancer based on a milliliter of blood[J]. Brief Bioinform, 2021, 22(1):536-544.
doi: 10.1093/bib/bbaa006 pmid: 32010933 |
[15] |
D'HONDT M, LAPOINTE R, BENAMIRA Z, et al. Carcinoma of the gallbladder: patterns of presentation, prognostic factors and survival rate. An 11-year single centre experience[J]. Eur J Surg Oncol, 2013, 39(6):548-553.
doi: 10.1016/j.ejso.2013.02.010 pmid: 23522952 |
[16] | 章正威, 王翔, 章应峰, 等. 意外胆囊癌组织中糖类抗原19-9和癌胚抗原表达的预后价值[J]. 黑龙江医学, 2023, 47(4):389-392. |
ZHANG Z W, WANG X, ZHANG Y F, et al. Prognostic value of carbohydrate antigen19-9 and carcinoma embryonic antigen expression in unexpected gallbladder carcinoma tissues[J]. Heilongjiang Med J, 2023, 47(4):389-392. | |
[17] | WANG X, YU Y, TAO Y, et al. Clinical-radiological characteristic for predicting ultra-early recurrence after liver resection in solitary hepatocellular carcinoma patients[J]. J Hepatocell Carcinoma, 2023,10:2323-2335. |
[18] | ZHAO H, WU L, YAN G, et al. Inflammation and tumor progression: signaling pathways and targeted intervention[J]. Signal Transduct Target Ther, 2021, 6(1):263. |
[19] | AI L, MU S, HU Y. Prognostic role of RDW in hematological malignancies: a systematic review and meta-analysis[J]. Cancer Cell Int, 2018,18:61. |
[20] | 龙云祥, 曲凯, 张靖垚, 等. 肝细胞癌术前红细胞分布宽度的预后价值[J]. 中华消化外科杂志, 2021, 20(2):205-212. |
LONG Y X, QU K, ZHANG J Y. Prognostic value of preoperative red blood cell distribution width for hepatocellular carcinoma[J]. Chin J Dig Surg, 2021, 20(2):205-212. | |
[21] |
LEI K, DENG Z, WANG J, et al. A novel nomogram based on the hematological prognosis risk scoring system can predict the overall survival of patients with hepatocellular carcinoma[J]. J Cancer Res Clin Oncol, 2023, 149(16):14631-14640.
doi: 10.1007/s00432-023-05255-3 pmid: 37584710 |
[22] | ŁOCHOWSKI M, ŁOCHOWSKA B, CHAŁUBIŃSKA-FENDLER J, et al. Prognostic factors determining survival of patients operated for non-small cell lung cancer with consideration given to morphological parameters of blood[J]. Cancer Manag Res, 2021,13:479-487. |
[23] |
LI Y, WU H, XING C, et al. Prognostic evaluation of colorectal cancer using three new comprehensive indexes related to infection, anemia and coagulation derived from peripheral blood[J]. J Cancer, 2020, 11(13):3834-3845.
doi: 10.7150/jca.42409 pmid: 32328188 |
[24] |
LI Y, XING C, WEI M, et al. Combining red blood cell distribution width (RDW-CV) and CEA predict poor prognosis for survival outcomes in colorectal cancer[J]. J Cancer, 2019, 10(5):1162-1170.
doi: 10.7150/jca.29018 pmid: 30854125 |
[25] | BENSON A B, D'ANGELICA M I, ABBOTT D E, et al. Guidelines insights: hepatobiliary cancers, version 2.2019[J]. J Natl Compr Canc Netw, 2019, 17(4):302-310. |
[26] | 耿智敏, 汤朝晖. 2018年NCCN指南更新版胆囊癌诊治进展述评[J]. 西部医学, 2018, 30(7):937-942,947. |
GENG Z M, TANG Z H. The development on diagnosis and management of gallbladder cancer:focus on the update of NCCN guideline in 2018[J]. Med J West China, 2018, 30(7):937-942,947. | |
[27] | BUTTE J M, GÖNEN M, ALLEN P J, et al. The role of laparoscopic staging in patients with incidental gallbladder cancer[J]. HPB (Oxford), 2011, 13(7):463-472. |
[1] | LU Zhongxiao, TANG Jie, HUANG Wenhai. Nomogram construction based on SEER and survival prediction of pancreatic cancer patients [J]. Journal of Surgery Concepts & Practice, 2024, 29(01): 46-53. |
[2] | LI Yuefeng, HONG Jin, LI Zhian, RUAN Guodong, CHEN Weiguo. Prognostic analysis of the patients with HER2-positive breast cancer adjuvant treated with trastuzumab: a report of 1 246 cases [J]. Journal of Surgery Concepts & Practice, 2023, 28(05): 469-476. |
[3] | WANG Shukui, GU Xinliang. Advances in the study of tsRNA as diagnostic and prognostic biomarkers in cancer [J]. Journal of Diagnostics Concepts & Practice, 2023, 22(05): 413-420. |
[4] | BAI Yaya, TANG Biwen, HU Yueliang, ZUO Junli, YAO Weiyan. Clinical characteristics and prognosis of eosinophilic gastroenteritis in 71 cases [J]. Journal of Internal Medicine Concepts & Practice, 2023, 18(04): 270-277. |
[5] | YANG Yi, YANG Xingxia, JIN Sili, ZHANG Xu, ZHU Juanying, CHEN Xiaosong. Clinical application of preoperative MRI examination in breast-conserving surgery for ductal carcinoma in situ [J]. Journal of Surgery Concepts & Practice, 2023, 28(04): 378-382. |
[6] | HU Jingjing, SHEN Yinzhong, LIU Li, LU Hongzhou. Current status and research progress of diagnosis and treatment of AIDS with disseminated non-tuberculous mycobacterial disease [J]. Journal of Diagnostics Concepts & Practice, 2023, 22(04): 402-406. |
[7] | ZHANG Lanlan, YANG Qiao, NIE Zunzhen, GUO Ying. Thoracic SMARCA4-deficient undifferentiated tumour: a case report [J]. Journal of Diagnostics Concepts & Practice, 2023, 22(04): 389-392. |
[8] | LIU Yingting, YI Hongmei, WANG Xue, YANG Chunxue, OUYANG Binshen XU Haimin, WANG Chaofu. Clinicopathological features and prognosis of 17 cases of duodenal-type follicular lymphoma [J]. Journal of Diagnostics Concepts & Practice, 2023, 22(04): 362-368. |
[9] | BAI Tingting, LI Feika, XU Gang, JIANG Qianwen, WU Fang. A simple prediction model for risk of functional impairment in elderly [J]. Journal of Internal Medicine Concepts & Practice, 2023, 18(03): 177-182. |
[10] | ZHOU Xiaodie, CHEN Weiwei, YU Bo, WANG Xuan, WANG Jianjun, SHI Qunli, RAO Qiu, BAO Wei. Clinicopathological features of urothelial carcinoma [J]. Journal of Diagnostics Concepts & Practice, 2023, 22(03): 292-299. |
[11] | WEI Jian, SUN Jie, CUI Shishuang. Development of a Nomogram model for early diagnosis of Parkinson disease [J]. Journal of Diagnostics Concepts & Practice, 2023, 22(03): 277-282. |
[12] | XU Li, GAO Huajie, YANG Mengge, LI Yue, JI Suqiong. Clinical characteristics of anti-SRP antibody positive immune-mediated necrotizing myopathy with anti-TRIM21/Ro52 antibody positive [J]. Journal of Diagnostics Concepts & Practice, 2023, 22(03): 247-254. |
[13] | QIAO Minjie, ZHOU Wei, CHEN Yi. Role of serum high mobility group box-B1 in evaluating prognosis of sepsis [J]. Journal of Internal Medicine Concepts & Practice, 2023, 18(02): 70-75. |
[14] | SONG Luqian, CHANG Chunkang. Interpretation of clinical practice guidelines for myelodysplastic syndrome (version 1, 2023) of National Comprehensive Cancer Nerwork(NCCN) [J]. Journal of Diagnostics Concepts & Practice, 2023, 22(02): 116-120. |
[15] | WANG Han, LU Haidi, WANG Lei, CONG Wenming, ZHENG Jianming, BAI Chenguang. Clinicopathological features of 2 cases of squamous cell carcinoma and 2 cases of adenosquamous carcinoma [J]. Journal of Diagnostics Concepts & Practice, 2023, 22(01): 44-49. |
Viewed | ||||||
Full text |
|
|||||
Abstract |
|
|||||